Certified by Founder Lodge
eGenesis, Inc.
United States - Cambridge, MA
START UP
1 Disclosed Funding Rounds $191,000,000
0 Participating Investments
-
Founded date
2015
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
eGenesis is revolutionizing the field of transplantation with an unparalleled, multiplexed gene editing platform for the development of human-compatible organs, tissues and cells. Harnessing
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| September, 04 ,2024 | Series B | $191,000,000 |
Lux Capital
ARCH Venture Partners
Farallon Capital Management
Leaps by Bayer
Alta Partners
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
TG0 | $5,619,170 | (Dec 20, 2024)
Double(US) | $3,900,000 | (Dec 20, 2024)
Mindgard | $8,000,000 | (Dec 20, 2024)
Hauler Hero | $10,000,000 | (Dec 20, 2024)
LeapFinancial | $3,500,000 | (Dec 20, 2024)
